Group 1 - The core viewpoint of the news is that Kangtong Medical has experienced a decline in stock performance and financial metrics, indicating potential challenges for the company [1][2]. - On February 26, Kangtong Medical's stock fell by 0.85%, with a trading volume of 33.36 million yuan. The net financing buy was -3.34 million yuan, indicating more repayments than new purchases [1]. - As of February 26, the total margin balance for Kangtong Medical was 136 million yuan, accounting for 7.66% of its market capitalization, which is above the 90th percentile of the past year [1]. Group 2 - For the period from January to September 2025, Kangtong Medical reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a decline of 150.92% [2]. - The company has distributed a total of 48.99 million yuan in dividends since its A-share listing [3]. - As of September 30, 2025, the number of shareholders for Kangtong Medical was 8,585, a decrease of 3.74% from the previous period, while the average circulating shares per person increased by 3.89% to 7,637 shares [2].
港通医疗2月26日获融资买入158.54万元，融资余额1.36亿元